Isoflurane preconditioning protects motor neurons from spinal cord ischemia: its dose-response effects and activation of mitochondrial adenosine triphosphate-dependent potassium channel

Neurosci Lett. 2005 Oct 21;387(2):90-4. doi: 10.1016/j.neulet.2005.06.072.

Abstract

We examined in a rabbit model of transient spinal cord ischemia (SCI) whether isoflurane (Iso) preconditioning induces ischemic tolerance to SCI in a dose-response manner, and whether this effect is dependent on mitochondrial adenosine triphosphate-dependent potassium (K(ATP)) channel. Eighty-six rabbits were randomly assigned to 10 groups: Control group (n=8) received no pretreatment. Ischemic preconditioning (IPC) group (n=8) received 5 min of IPC 30 min before SCI. The Iso 1, Iso 2 and Iso 3 groups (n=10, 9, 8) underwent 30 min of 1.05, 2.1 and 3.15% Iso inhalation commencing 45 min before SCI. The Iso 1HD, Iso 2HD and Iso 3HD groups (n=9, 9, 8) each received a specific mitochondrial K(ATP) channel blocker, 5-hydroxydecanoic acid (5HD, 20mg/kg), 5 min before each respective Iso inhalation. The 5HD group (n=8) received 5HD without Iso inhalation. The sham group (n=9) had no SCI. SCI was produced by infra-renal aortic occlusion via the inflated balloon of a Swan-Ganz catheter for 20 min. The Iso 1, Iso 2 and Iso 3 groups showed a better neurologic outcome and more viable motor nerve cells (VMNCs) in the anterior spinal cord 72 h after reperfusion than the control group (p<0.05). Iso 3 group showed a better neurologic outcome and more VMNCs than Iso 1 group (p<0.05). And, the Iso 1, Iso 2 and Iso 3 groups showed a better neurologic outcome and higher VMNC numbers than the corresponding Iso 1HD, Iso 2HD and Iso 3HD groups (p<0.05). This study demonstrates that Iso preconditioning protects the spinal cord against neuronal damage due to SCI in a dose-response manner via the activation of mitochondrial K(ATP) channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Inhalation / pharmacology
  • Animals
  • Anterior Horn Cells / drug effects*
  • Anterior Horn Cells / metabolism
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Ischemic Preconditioning / methods*
  • Isoflurane / pharmacology*
  • Male
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / physiopathology
  • Nerve Degeneration / prevention & control
  • Neuroprotective Agents / pharmacology
  • Potassium Channels / drug effects*
  • Potassium Channels / metabolism
  • Rabbits
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / prevention & control
  • Spinal Cord / blood supply
  • Spinal Cord / metabolism
  • Spinal Cord / physiopathology
  • Spinal Cord Ischemia / drug therapy*
  • Spinal Cord Ischemia / physiopathology
  • Spinal Cord Ischemia / prevention & control*

Substances

  • Anesthetics, Inhalation
  • Neuroprotective Agents
  • Potassium Channels
  • mitochondrial K(ATP) channel
  • Isoflurane